Search research articles
Contact Us
Filters
Showing results (631-640 of 672) with videos related to
Page
of 68
Sort By:
Arthritis Care & Research
|
April 19, 2018
Core Curriculum to Facilitate the Expansion of a Rheumatology Practice to Include Nurse Practitioners and Physician Assistants
Benjamin J Smith, Marcy B Bolster, Barbara Slusher, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Journal of Medicinal Chemistry
|
September 10, 2019
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
Eva Prchalová, Niyada Hin, Ajit G Thomas, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 29, 2021
Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Proteomics
|
June 25, 2019
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
Sunag Udupa, Stephanie Nguyen, Giang Hoang, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 2, 2023
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
Shveta Bathla, Dibyadeep Datta, Feng Liang, et al.
Research Square
|
July 28, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Translational Neurodegeneration
|
December 4, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Scientific Reports
|
December 12, 2018
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
Camilo Rojas, Elena Barnaeva, Ajit G Thomas, et al.
Page
of 68
Search research articles
Search
Showing results (631-640 of 672) with videos related to
Sort By:
Page
of 68
Arthritis Care & Research
|
April 19, 2018
Core Curriculum to Facilitate the Expansion of a Rheumatology Practice to Include Nurse Practitioners and Physician Assistants
Benjamin J Smith, Marcy B Bolster, Barbara Slusher, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Journal of Medicinal Chemistry
|
September 10, 2019
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
Eva Prchalová, Niyada Hin, Ajit G Thomas, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 29, 2021
Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Proteomics
|
June 25, 2019
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
Sunag Udupa, Stephanie Nguyen, Giang Hoang, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 2, 2023
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
Shveta Bathla, Dibyadeep Datta, Feng Liang, et al.
Research Square
|
July 28, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Translational Neurodegeneration
|
December 4, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model
Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Scientific Reports
|
December 12, 2018
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
Camilo Rojas, Elena Barnaeva, Ajit G Thomas, et al.
Page
of 68